参考文献/References:
[1] Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge[J].N Engl J Med, 2007,356(3):213-215. DOI:10.1056/NEJMp068177.
[2] Myers MG Jr, Olson DP. Central nervous system control of metabolism[J].Nature, 2012,491(7424):357-363. DOI: 10.1038/nature11705.
[3] 初建芳, 韩林, 金心. 黑皮质素受体4与肥胖研究进展[J]. 中国儿童保健杂志, 2009,17(6):682-684.
[4] Clemmensen C, Finan B, Fischer K,et al. Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice[J].EMBO Mol Med,2015,7(3):288-298.DOI: 10.15252/emmm.201404508.
[5] Qu H, Li J, Chen W,et al. Differential expression of the melanocortin-4 receptor in male and female C57BL/6J mice[J].Mol Biol Rep, 2014,41(5):3245-3256.DOI: 10.1007/s11033-014-3187-5.
[6] Morgan DA, McDaniel LN, Yin T,et al. Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus[J].Diabetes, 2015,64(6):1976-1987. DOI: 10.2337/db14-1257.
[7] Fani L, Bak S, Delhanty P,et al. The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options[J].Int J Obes(Lond), 2014,38(2):163-169. DOI: 10.1038/ijo.2013.80.
[8] Siljee JE, Unmehopa UA, Kalsbeek A,et al. Melanocortin 4 receptor distribution in the human hypothalamus[J].Eur J Endocrinol, 2013,168(3):361-369. DOI: 10.1530/EJE-12-0750.
[9] Lazopoulou N, Gkioka E, Ntalla I,et al. The combined effect of MC4R and FTO risk alleles on childhood obesity in Greece[J].Hormones(Athens), 2015,14(1):126-133. DOI: 10.14310/horm.2002.1524.
[10] Arble DM, Holland J, Ottaway N,et al. The melanocortin-4 receptor integrates circadian light cues and metabolism[J]. Endocrinology, 2015,156(5):1685-1691.DOI: 10.1210/en.2014-1937.
[11] Kumar KG, Sutton GM, Dong JZ,et al. Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice[J].Peptides, 2009,30(10):1892-1900. DOI: 10.1016/j.peptides.2009.07.012.
[12] do Carmo JM, da Silva AA, Rushing JS,et al. Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons[J].Am J Physiol Regul Integr Comp Physiol, 2013,305(4):R359-R368. DOI: 10.1152/ajpregu.00518.2012.
[13] Xu Y, Elmquist JK, Fukuda M. Central nervous control of energy and glucose balance: focus on the central melanocortin system[J].Ann N Y Acad Sci, 2011,1243:1-14. DOI: 10.1111/j.1749-6632.2011.06248.x.
[14] Hansen MJ, Schi?th HB, Morris MJ. Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet[J].Brain Res, 2005,1039(1-2):137-145. DOI:10.1016/j.brainres.2005.01.063.
[15] Kievit P, Halem H, Marks DL,et al. Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques[J].Diabetes, 2013,62(2):490-497. DOI: 10.2337/db12-0598.
[16] Monge-Roffarello B, Labbe SM, Lenglos C,et al. The medial preoptic nucleus as a site of the thermogenic and metabolic actions of melanotan Ⅱ in male rats[J].Am J Physiol Regul Integr Comp Physiol, 2014,307(2):R158-R166. DOI:10.1152/ajpregu.00059.2014.
[17] Kooijman S, Boon MR, Parlevliet ET,et al. Inhibition of the central melanocortin system decreases brown adipose tissue activity[J].J Lipid Res, 2014,55(10):2022-2032. DOI: 10.1194/jlr.M045989.
[18] Balthasar N, Dalgaard LT, Lee CE,et al. Divergence of melanocortin pathways in the control of food intake and energy expenditure[J].Cell, 2005,123(3):493-505.
[19] Kumar KG, Sutton GM, Dong JZ,et al. Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice[J].Peptides,2009,30(10):1892-1900. DOI: 10.1016/j.peptides.2009.07.012.
[20] Morgan DA, McDaniel LN, Yin T, et al.Regulation of glucose tolerance and sympathetic activity by MC4R signaling in the lateral hypothalamus[J].Diabetes,2015,64(6):1976-1987. DOI: 10.2337/db14-1257.
[21] Rossi J, Balthasar N, Olson D,et al. Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis[J].Cell Metab, 2011,13(2):195-204. DOI: 10.1016/j.cmet.2011.01.010.
[22] Panaro BL, Tough IR, Engelstoft MS,et al. The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo[J].Cell Metab, 2014,20(6):1018-1029. DOI: 10.1016/j.cmet.2014.10.004.
相似文献/References:
[1]柯孟婷,孙家忠,李扬.3,5-二碘-L-甲状腺素对白色脂肪棕色化的作用[J].国际内分泌代谢杂志,2016,36(06):370.[doi:10.3760/cma.j.issn.1673-4157.2016.06.03]
Ke Mengting*,Sun Jiazhong,Li Yang..Effects of 3,5-diiodo-L-thyronine on browning of white adipose tissue[J].International Journal of Endocrinology and Metabolism,2016,36(06):370.[doi:10.3760/cma.j.issn.1673-4157.2016.06.03]
[2]高胜利,郭菲菲,徐珞,等.Nesfatin-1与肥胖的关系[J].国际内分泌代谢杂志,2016,36(06):384.[doi:10.3760/cma.j.issn.1673-4157.2016.06.06]
Gao Shengli,Guo Feifei,Xu Luo,et al.Relationship between nesfatin-1 and obesity[J].International Journal of Endocrinology and Metabolism,2016,36(06):384.[doi:10.3760/cma.j.issn.1673-4157.2016.06.06]
[3]杨曦,刘玉洁,马慧娟.生长分化因子15与肥胖及糖尿病[J].国际内分泌代谢杂志,2016,36(06):388.[doi:10.3760/cma.j.issn.1673-4157.2016.06.07]
Yang Xi*,Liu Yujie,Ma Huijuan..Growth differentiation factor-15 and obesity, diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):388.[doi:10.3760/cma.j.issn.1673-4157.2016.06.07]
[4]姚旻,赵爱源,李红涛,等.人体肥胖指数在评价2型糖尿病患者
肥胖中的应用价值[J].国际内分泌代谢杂志,2017,37(01):1.[doi:10.3760/cma.j.issn.1673-4157.2017.01.01]
Yao Min*,Zhao Aiyuan,Li Hongtao,et al.Body adiposity index and its value in obesity evaluation in patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2017,37(06):1.[doi:10.3760/cma.j.issn.1673-4157.2017.01.01]
[5]严克敏,朱惠娟,龚凤英.雷公藤红素:一种潜在的治疗肥胖症的新药物[J].国际内分泌代谢杂志,2017,37(01):32.[doi:10.3760/cma.j.issn.1673-4157.2017.01.09]
Yan Kemin,Zhu Huijuan,Gong Fengying..Celastrol:a potential and novel drug for obesity[J].International Journal of Endocrinology and Metabolism,2017,37(06):32.[doi:10.3760/cma.j.issn.1673-4157.2017.01.09]
[6]张群慧,陈明卫.miRNA与肥胖[J].国际内分泌代谢杂志,2017,37(01):35.[doi:10.3760/cma.j.issn.1673-4157.2017.01.10]
Zhang Qunhui,Chen Mingwei..microRNA and obesity[J].International Journal of Endocrinology and Metabolism,2017,37(06):35.[doi:10.3760/cma.j.issn.1673-4157.2017.01.10]
[7]梁绮君,胡晨鸣,黄容,等.山楂消脂胶囊对肥胖症患者炎性状态
及脂多糖水平的影响[J].国际内分泌代谢杂志,2017,37(04):236.
Liang Qijun,Hu Chenming,Huang Rong,et al.Effects of Shanzha xiaozhi capsule on inflammation and lipopolysaccharide level in obese patients[J].International Journal of Endocrinology and Metabolism,2017,37(06):236.
[8]马骥,都健.代谢手术影响骨代谢的机制研究[J].国际内分泌代谢杂志,2017,37(05):312.
Ma Ji,Du Jian..Mechanism study of effects of metabolic surgery on bone metabolism[J].International Journal of Endocrinology and Metabolism,2017,37(06):312.
[9]张灿 李宝新 郭淑芹 常文龙 王翯 姚琪 张云良.2型糖尿病合并肥胖患者血清Irisin
和SFRP5水平变化的研究[J].国际内分泌代谢杂志,2018,38(01):1.[doi:10.3760/cma.j.issn.1673-4157.2018.01.001]
Zhang Can*,Li Baoxin,Guo Shuqin,et al.The changes of serum Irisin and SFRP5 levels in obese patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(06):1.[doi:10.3760/cma.j.issn.1673-4157.2018.01.001]
[10]陈琦 袁莉.γ-氨基丁酸能信号系统与胰岛素抵抗[J].国际内分泌代谢杂志,2020,40(02):113.[doi:10.3760/cma.j.issn.1673-4157.2020.02.010]
Chen Qi,Yuan Li.Relationship between γ-aminobutyric acid signaling system and insulin resistance[J].International Journal of Endocrinology and Metabolism,2020,40(06):113.[doi:10.3760/cma.j.issn.1673-4157.2020.02.010]